N Rifai

Author PubWeight™ 197.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000 18.04
2 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 15.85
3 Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 8.17
4 Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001 7.51
5 Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001 5.67
6 Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001 5.54
7 Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001 4.31
8 Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999 3.90
9 Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000 3.66
10 Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001 3.59
11 Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998 3.19
12 Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001 3.17
13 Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001 3.12
14 Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 2001 2.81
15 Blood pressure and inflammation in apparently healthy men. Hypertension 2001 2.55
16 Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 1997 2.34
17 Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1996 2.31
18 Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001 2.01
19 Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999 1.96
20 C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998 1.96
21 The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int 2006 1.84
22 Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007 1.80
23 Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000 1.74
24 Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001 1.69
25 False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998 1.63
26 Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001 1.63
27 Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol 2000 1.62
28 Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 1999 1.61
29 Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem 2000 1.58
30 Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem 2000 1.52
31 Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001 1.50
32 Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999 1.47
33 Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998 1.43
34 Evaluation of the APEC analyzer for whole blood glucose. Testing in a pediatric setting. Am J Clin Pathol 1995 1.39
35 Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 2000 1.33
36 Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998 1.32
37 Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab 2004 1.31
38 Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 1999 1.22
39 Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity. J Pharmacol Exp Ther 1995 1.17
40 Effect of vitamin supplementation to HIV-infected pregnant women on the micronutrient status of their infants. Eur J Clin Nutr 2005 1.12
41 Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children? J Clin Microbiol 1990 1.11
42 Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001 1.11
43 Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 1999 1.08
44 Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. Clin Biochem 1995 1.07
45 Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia 2004 1.07
46 Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol 1999 1.06
47 Sciatic nerve blockade in infant, adolescent, and adult rats: a comparison of ropivacaine with bupivacaine. Anesthesiology 1998 1.06
48 Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men. Int J Obes Relat Metab Disord 2001 1.06
49 Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. Clin Chem 1986 1.05
50 Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord 2000 1.05
51 Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997 1.05
52 Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem 2000 1.04
53 Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther 2004 1.01
54 Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population. Clin Biochem 2000 0.99
55 Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord 2001 0.98
56 Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 2000 0.98
57 Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 2000 0.98
58 Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method. Clin Chim Acta 2000 0.98
59 Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr 1998 0.97
60 Role of free radicals in cancer and atherosclerosis. Clin Lab Med 1993 0.97
61 A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. Diabetologia 2005 0.95
62 Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr 2000 0.95
63 Tandem mass spectrometry method for the quantification of serum busulfan. Ther Drug Monit 2005 0.95
64 Hyperlipemic response of young trained and untrained men after a high fat meal. Arteriosclerosis 1989 0.93
65 Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Infect Immun 1989 0.92
66 Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia 2004 0.92
67 High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem 2000 0.91
68 Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women. Diabet Med 2005 0.91
69 International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators. Clin Chem 1998 0.91
70 Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr 2005 0.90
71 Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res 1998 0.90
72 The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol 2001 0.90
73 Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res 1998 0.89
74 High-sensitivity C-reactive protein, adiposity, and blood pressure in the Yakut of Siberia. Am J Hum Biol 2006 0.89
75 Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int 2006 0.89
76 Blood lead and hemoglobin levels in Andean children with chronic lead intoxication. Neurotoxicology 2000 0.88
77 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein(a). Clin Chem Lab Med 1999 0.88
78 A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole. Ann N Y Acad Sci 1995 0.87
79 Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am J Cardiol 1997 0.86
80 High sensitivity immunoassays for C-reactive protein: promises and pitfalls. Clin Chem Lab Med 2001 0.86
81 Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. J Am Coll Cardiol 1998 0.85
82 Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein, and apolipoprotein concentrations in premenopausal and postmenopausal women. Arterioscler Thromb 1991 0.85
83 Serum lipids, neuroendocrine, and cardiovascular responses to stress in men and women with mild hypertension. Behav Med 1994 0.85
84 Effects of a single bout of ultraendurance exercise on lipid levels and susceptibility of lipids to peroxidation in triathletes. JAMA 1996 0.84
85 Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease. Arch Pathol Lab Med 1986 0.84
86 Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. J Heart Lung Transplant 2000 0.84
87 Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. J Clin Endocrinol Metab 2007 0.83
88 Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab 2001 0.83
89 A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United States. Clin Chem Lab Med 2000 0.82
90 Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients. Arch Pediatr Adolesc Med 1998 0.82
91 Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc Med 2001 0.82
92 Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem 1987 0.81
93 Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents. Rev Panam Salud Publica 2000 0.81
94 Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. J Clin Endocrinol Metab 2001 0.81
95 Efficacy of felbamate in therapy for partial epilepsy in children. J Pediatr 1994 0.80
96 Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII. Clin Chem 1986 0.80
97 Urinary N-acetyl-beta-glucosaminidase and beta-2-microglobulin in the diagnosis of urinary tract infection in febrile infants. Pediatr Infect Dis J 1994 0.80
98 Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. Clin Chem 1997 0.79
99 Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. Clin Chem 1996 0.79
100 Effective control of hypercholesterolemia in children with dietary interventions based in pediatric practice. Prev Med 1993 0.79
101 Vitamin A status in acute exacerbations of cystic fibrosis. Am J Clin Nutr 1996 0.79
102 The effect of low-dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins. Pharmacotherapy 1986 0.79
103 Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlon. Ginsburg-gender and exercise-induced lipid peroxidation. Clin Chim Acta 2001 0.79
104 Performance characteristics of a point of care C-reactive protein assay. Clin Chim Acta 2001 0.78
105 Apolipoprotein E is released by rat sciatic nerve during segmental demyelination and remyelination. J Neuropathol Exp Neurol 1987 0.78
106 A preliminary study of urinary transferrin as a marker for prostatic cancer. Clin Chim Acta 1986 0.78
107 Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 2000 0.78
108 Markers of the acute phase response in cardiovascular disease: an update. Clin Chem Lab Med 2001 0.78
109 Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Ann Clin Lab Sci 1988 0.78
110 Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest 2006 0.77
111 Prolonged survival in pyruvate carboxylase deficiency: lack of correlation with enzyme activity in cultured fibroblasts. Clin Biochem 1995 0.77
112 Immunoturbidimetric assay of transferrin: effect of iron and need for serum blanks. Clin Biochem 1986 0.77
113 Race and gender differences in cord blood lipoproteins. Atherosclerosis 2000 0.77
114 A simple immunotechnique for the determination of serum concentration of apolipoprotein E. Clin Chim Acta 1987 0.76
115 Apolipoprotein and lipoprotein cholesterol concentrations in trained and sedentary males. Clin Chim Acta 1987 0.76
116 Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference Method. Clin Chem 1996 0.76
117 Stress reactivity and exercise training in premenopausal and postmenopausal women. Health Psychol 1991 0.76
118 Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol 2001 0.76
119 Virilising 21-hydroxylase deficiency: timing of newborn screening and confirmatory tests can be crucial. J Pediatr Endocrinol Metab 2000 0.75
120 The pharmacokinetics of epidural ropivacaine in infants and young children. Anesth Analg 2001 0.75
121 Serum retinol-binding protein and creatinine in onset of and recovery from acute renal failure. Clin Chem 1987 0.75
122 A receptor assay for serum low density lipoprotein-apolipoprotein B-100: preliminary report. Clin Chim Acta 1992 0.75
123 Automated determination of apolipoprotein AI and apolipoprotein E in cerebrospinal fluid. Clin Chem 1986 0.75
124 Measurement of methsuximide and N-desmethylmethsuximide using solid-phase extraction and wide-bore capillary gas chromatography. Clin Biochem 1988 0.75
125 Immunoturbidimetry of transthyretin (prealbumin) in human serum. Clin Chem 1987 0.75
126 Cholesterol testing in the physician's office: accuracy assessment. Am J Dis Child 1991 0.75
127 [Role of beta-2-mimetic agents in the treatment of asthma]. Allerg Immunol (Paris) 1990 0.75
128 [Cholangio-hamartoma of the liver (a new case)]. Maroc Med 1984 0.75
129 Acute changes in serum lipids and lipoprotein subclasses in triathletes as assessed by proton nuclear magnetic resonance spectroscopy. Arterioscler Thromb Vasc Biol 1999 0.75
130 Standardization of lipoprotein reporting. Am J Clin Pathol 2000 0.75
131 Immunoturbidimetric measurement of serum retinol-binding protein in renal and hepatic disease. Ann Clin Biochem 1988 0.75
132 Correlations of cardiovascular disease risk factors between African American siblings. J Pediatr 2000 0.75
133 Assessment of the immunoreactivity of digoxin metabolites and the cross-reactivity with digoxin-like immunoreactive factors in the Roche-TDM ONLINE digoxin assay. Ther Drug Monit 1995 0.75
134 Development of a radioreceptor assay to measure glucocorticoids. Ther Drug Monit 1992 0.75
135 Clinical chemistry and coagulation. Curr Opin Lipidol 1994 0.75
136 Lead poisoning in young children in Washington, DC: a crisis that remains to be addressed. Am J Dis Child 1992 0.75
137 Hemoglobin "Hope" interferes with measurement of glycated hemoglobin by ion-exchange chromatography and electrophoresis. Clin Chem 1984 0.75
138 Biochemical effects of 17 beta-estradiol on UMR106 cells. Bone Miner 1989 0.75
139 Role of the clinical laboratory in evaluation of argininosuccinate lyase deficiency. Clin Chem 1991 0.75
140 Intrafamilial relations of cardiovascular disease risk factors in African-Americans: longitudinal results from DC SCAN. Prev Med 1999 0.75
141 Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls. Clin Chem 2000 0.75